<DOC>
	<DOCNO>NCT00599287</DOCNO>
	<brief_summary>The purpose pilot-trial feasibility large randomize , placebo control , doubleblind clinical trial investigate use methylphenidate , rivastigmine haloperidol hypoactive ICU-delirium . In addition compare duration delirium , severity delirium , length ICU/hospital stay side effect different intervention .</brief_summary>
	<brief_title>Methylphenidate , Rivastigmine Haloperidol Hypoactive Delirium Intensive Care Patients</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Older 18 year Diagnosed hypoactive delirium Informed consent give Pregnancy Epilepsy M. Parkinson Lewybody dementia Prolonged QTtime Known allergy medicinals use Renal replacement therapy Hepatic encephalopathy Hyperthyroid Glaucoma Previous suicide attempt Syndrome Gilles de la Tourette Patients receive medication oral nasogastric tube</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>ICU delirium</keyword>
	<keyword>Hypoactive delirium</keyword>
	<keyword>Haloperidol</keyword>
	<keyword>Methylphenidate</keyword>
	<keyword>Rivastigmine</keyword>
	<keyword>Hypoactive ICU delirium</keyword>
</DOC>